Quest Diagnostics (DGX) Cash from Investing Activities (2009 - 2026)

Quest Diagnostics has reported Cash from Investing Activities for 18 years, with the latest figure at -$134.0 million in Q2 2026.

• Quarterly Cash from Investing Activities fell 8.06% year-over-year to -$134.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$678.0 million (up 71.44% YoY) and the FY2025 annual result came in at -$631.0 million, up 75.24% from the prior year.
• Cash from Investing Activities climbed to -$134.0 million in Q2 2026 per DGX's latest filing, from -$152.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$82.0 million in Q2 2022 and troughed at -$1.6 billion in Q3 2024.
• A 5-year average of -$281.6 million and a median of -$163.5 million in 2022 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2024 and 2025: Cash from Investing Activities slumped 1426.17% in 2024, then jumped 87.69% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$174.0 million in 2022, then soared by 34.48% to -$114.0 million in 2023, then sank by 340.35% to -$502.0 million in 2024, then jumped by 61.95% to -$191.0 million in 2025, then rose by 29.84% to -$134.0 million in 2026.
• According to Business Quant data, Cash from Investing Activities over the past three periods registered -$134.0 million, -$152.0 million, and -$191.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.